US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 7.255
- +0.015+0.21%
Trading Aug 8 09:40 ET
303.65MMarket Cap-5496P/E (TTM)
7.410High7.221Low18.40KVolume7.380Open7.240Pre Close135.32KTurnover0.05%Turnover RatioLossP/E (Static)41.85MShares8.44052wk High6.22P/B261.74MFloat Cap3.89052wk Low--Dividend TTM36.08MShs Float418.400Historical High--Div YieldTTM2.61%Amplitude2.560Historical Low7.353Avg Price1Lot Size
About Zevra Therapeutics Company
Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Company Profile
SymbolZVRA
Company NameZevra Therapeutics
Listing DateApr 16, 2015
Founded2006
CEOMr. Neil F. McFarlane, M.S.
MarketNASDAQ
Employees69
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1180 Celebration Boulevard,Suite 103
CityCelebration
ProvinceFlorida
CountryUnited States of America
Zip Code34747
Phone1-321-939-3416
Websitehttp://zevra.com
Company Executives
- Name
- Position
- Salary
- Neil F. McFarlane, M.S.
- Director, President and Chief Executive Officer
- 3.45M
- Christal M M. Mickle, M.A.
- Chief Development Officer
- 1.67M
- R. LaDuane Clifton, C.P.A.,M.B.A.
- Chief Financial Officer, Secretary and Treasurer
- 2.26M
- Joshua Schafer, M.B.A.
- Chief Commercial Officer and Executive Vice President, Business Development
- 1.82M
- Dr. Adrian Quartel, M.D.
- Chief Medical Officer
- --
- Dr. Sven Guenther, PhD
- Chief Scientific Officer
- --
- Timothy J. Sangiovanni
- Senior Vice President, Corporate Controller and Principal Accounting Officer
- --
- Tamara A. Favorito
- Chairman of the Board
- 324.39K
- Dr. Alvin Shih, M.D.
- Director
- --
- John B. Bode
- Independent Director
- 264.31K
- Thomas Anderson
- Independent Director
- 243.04K
- Corey Watton
- Independent Director
- 260.67K
- Douglas W. Calder
- Independent Director
- 258.02K
- Dr. Wendy L. Dixon, PhD
- Independent Director
- 274.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg